Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein H1 pseudogene 2 (HNRNPH1P2)

Target
HNRNPH1P2
Molecular classification
Other (Pseudogene)
01

Overview

HNRNPH1P2, or heterogeneous nuclear ribonucleoprotein H1 pseudogene 2, is classified as a pseudogene—a non-functional or transcriptionally inactive DNA sequence related to the functional RNA-binding protein gene **HNRNPH1**[2][5]. Unlike the functional gene, HNRNPH1P2 does not encode an RNA-binding protein involved in alternative splicing, RNA stability, or disease pathogenesis. While some pseudogenes play regulatory roles in gene expression by acting as microRNA sponges or competitive endogenous RNAs, there is no specific literature indicating that HNRNPH1P2 itself serves these roles. The pathogenic and therapeutic relevance in cancer, autoimmune disease, and neurodegeneration pertains to **HNRNPH1**, not to its pseudogene HNRNPH1P2[1][2][5].

Other names
HNRNPH1P2Heterogeneous nuclear ribonucleoprotein H1 pseudogene 2
02

Mechanism of action

None established.

03

Biological functions

Pseudogenes like *HNRNPH1P2* may function as *microRNA decoys* or *regulatory RNAs* through competitive endogenous RNA (ceRNA) mechanisms, but no well-documented biological function of HNRNPH1P2 specifically is available[5].
04

Disease associations

Other (No well-established disease association for HNRNPH1P2 specifically. Functional roles are described for HNRNPH1 instead[1][2].)Pseudogenes can modulate oncogene or tumor suppressor expression in some cases, but direct evidence for HNRNPH1P2's involvement is lacking[5].
05

Safety considerations

None documented. As a pseudogene, *HNRNPH1P2* does not encode a functional protein and is not a drug target.
06

Interacting drugs

None known for HNRNPH1P2.
07

Biomarkers

None established for HNRNPH1P2 specifically.

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein H1 pseudogene 2 (HNRNPH1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein H1 pseudogene 2 (HNRNPH1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call